Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fidelity® Extended Market Index Fund Investor Class (FSEMX)

Net Asset Value
1 Day
Overall Morningstar Rating
Mid-cap blend
Style or Category
No Load
Sales Expenses
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks to provide investment results that correspond to the total return of stocks of mid- to small-capitalization United States companies. The fund normally invests at least 80% of assets in common stocks included in the Dow Jones U.S. Completion Total Stock Market IndexSM, which represents the performance of stocks of mid- to small-capitalization U.S. companies. It uses statistical sampling techniques based on such factors as capitalization, industry exposures, dividend yield, price/earnings (P/E) ratio, price/book (P/B) ratio, and earnings growth to attempt to replicate the returns of the index using a smaller number of securities.


1 month+0.90% 3 years+8.25%
3 months+6.89% 5 years+14.33%
1 year+9.17% Since inception+7.63%
Data through --

Peer Comparisonvs. Mid-cap blend

Performance 5-yr return+14.33%+8.26%
Expense ratio0.10%1.16%
Risk 5 year sharpe ratio0.760.74
Net assets$16.6B$1.7B
Average market cap$3.3B$6.8B
Average P/E20.218.5
Portfolio turnover12%12%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyFidelity Investments
Fund manager & tenurePatrick Waddell / 12 Years
Minimal initial investment$2,500.00
Minimum IRA investment$2,500.00


U.S. stock97.79%
International stock1.95%
Fixed income0.10%
Top 5 Sectors
Portfolio weighting
Financial service 20.22%
Industrial materials 14.90%
Healthcare 10.49%
Consumer service 8.72%
Consumer goods 8.30%
Top 10 Holdings
Portfolio weighting
CHTR Charter Communications Inc1.12%
TSLA Tesla0.63%
LBTYK Liberty Global PLC0.59%
LVS Las Vegas Sands Corp0.42%
LNKD LinkedIn0.39%
BMRN Biomarin Pharmaceutical Inc0.36%
INCY Incyte Corp0.36%
TDG TransDigm Group Inc0.35%
MKL Markel Corp0.33%
QVCA Liberty Interactive Corp0.31%

Partner Offers